-Bruce G Pollock Researcher Activity Profile

Research Author Detailed Information 

Bruce G Pollock Publication Rate By Year

Bruce G Pollock has published 2 paper(s) in 2003, 6 paper(s) in 2006, 11 paper(s) in 2007, 2 paper(s) in 2008, for a total of 21 research publications in total.

Bruce G Bg Pollock Author Information

LAST NAME: pollock

FIRST NAME: Bruce G

INITIALS: bg

AFFILIATION:

Papers

Bruce G Pollock's Publication Record

1. The relationship of an anticholinergic rating scale with serum anticholinergic activity in elderly nursing home residents. Year Published: 2003
University of Iowa, Iowa City, Iowa, USA.
2. An Intent-to-Treat Method for Enhancing Analysis of Clinical Trials with Rescue Medication: A Mixed-Model Approach. Year Published: 2003
Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. houckpr@msx.upmc.edu
3. Relevance of assessing drug concentration exposure in pharmacogenetic and imaging studies. Year Published: 2006
Department of Psychiatry, Western Psychiatric Institute and Clinics, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
4. CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly. Year Published: 2006
Western Psychiatric Institute and Clinic, Department of Psychiatry, University of Pittsburgh School of Medicine, USA.
5. Paroxetine treatment of primary insomnia in older adults. Year Published: 2006
Advanced Center for Interventions and Services Research for Late-Life Mood Disorders (ACISR/LLMD) and the John A. Hartford Center of Excellence in Geriatric Psychiatry, Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA. Reynoldscf@upmc.edu
6. A model of anticholinergic activity of atypical antipsychotic medications. Year Published: 2006
Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261, USA.
7. The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. Year Published: 2006
University of Oklahoma College of Pharmacy, Department of Pharmacy, Tulsa, Oklahoma 74315-2512, USA. ryan-carnahan@ouhsc.edu
8. Population pharmacokinetics in geriatric psychiatry. Year Published: 2006
Department of Pharmaceutical Sciences, University of Pittsburgh, School of Pharmacy, Pittsburgh, PA 15261, USA. klb110@pitt.edu
9. Emergence, persistence, and resolution of suicidal ideation during treatment of depression in old age. Year Published: 2007
University of Pittsburgh School of Medicine, Department of Psychiatry, Pittsburgh, Pennsylvania 15213, United States. szantok@upmc.edu
10. Serum anticholinergic activity and motor performance in elderly persons. Year Published: 2007
Department of Psychiatry, University of Pittsburgh Medical Center, Pennsylvania, USA. nebesrd@upmc.edu
11. Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study. Year Published: 2007
Western Psychiatric Institute and Clinic, 3811 O'Hara Street, Room E 823, Pittsburgh, PA15213, USA. Lenzee@upmc.edu.
12. Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy. Year Published: 2007
Department of Psychiatry, University of Pittsburgh School of Medicine and Western Psychiatric Institute and Clinic, 3811 O'Hara St., Pittsburgh, PA 15213, USA. dewma@upmc.edu
13. Depression following pegylated interferon-alpha: characteristics and vulnerability. Year Published: 2007
Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA. lotrichfe@upmc.edu
14. Lower central serotonergic responsivity is associated with preclinical carotid artery atherosclerosis. Year Published: 2007
Center for Clinical Pharmacology, University of Pittsburgh, Pittsburgh, PA 15260, USA. mfm10@pitt.edu
15. Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy. Year Published: 2007
Western Psychiatric Institute and Clinic, Department of Psychiatry, School of Medicine, University of Pittsburgh, Pennsylvania, USA.
16. Depression following pegylated interferon-alpha: characteristics and vulnerability. Year Published: 2007
Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA. lotrichfe@upmc.edu
17. A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. Year Published: 2007
Rotman Research Institute at Baycrest, Toronto, Ontario, Canada. bpollock@rotman-baycrest.on.ca
18. A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. Year Published: 2007
Rotman Research Institute at Baycrest, Toronto, Ontario, Canada. bpollock@rotman-baycrest.on.ca
19. Sex, race, and smoking impact olanzapine exposure. Year Published: 2008
PharmD, University of Pittsburgh, School of Pharmacy, 805 Salk Hall, 3501 Terrace St, Pittsburgh, PA 15261; e-mail: rrb47@pitt.edu.
20. A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. Year Published: 2007
Rotman Research Institute at Baycrest, Toronto, Ontario, Canada. bpollock@rotman-baycrest.on.ca
21. Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients. Year Published: 2008
NIMH Advanced Center in Interventions and Services Research for Late-Life Mood Disorders and the John A. Hartford Foundation Center of Excellence in Geriatric Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. lotrichfe@upmc.edu